Title:
自己免疫疾患の処置のためのJAKキナーゼの阻害剤としての2,4-ピリミジンアミン誘導体
Document Type and Number:
Japanese Patent JP5161233
Kind Code:
B2
Abstract:
The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.
Inventors:
Refui
Argade ankush
Tota Sun Bear
Carol david
Llan Albinder
Cooper robin
Thing Razinder
Zokin
Bamidy Patty Soma Secker
Argade ankush
Tota Sun Bear
Carol david
Llan Albinder
Cooper robin
Thing Razinder
Zokin
Bamidy Patty Soma Secker
Application Number:
JP2009533582A
Publication Date:
March 13, 2013
Filing Date:
October 19, 2007
Export Citation:
Assignee:
Rigel Pharmaceuticals, Inc.
International Classes:
C07D239/48; A61K31/505; A61K31/506; A61K31/5377; A61K31/5415; A61K45/00; A61P37/06; A61P43/00; C07D401/12; C07D401/14; C07D403/12; C07D405/12; C07D417/12; C07D419/14; C07D498/04
Domestic Patent References:
| JP2004517925A | ||||
| JP2009524632A |
Foreign References:
| WO2004046118A2 |
Attorney, Agent or Firm:
Hatsushi Shimizu
Toshi Gobe
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Ryuichi Inoue
Masato Ozeki
Toshi Gobe
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Ryuichi Inoue
Masato Ozeki